Table 2 Covariates associated with H. pylori infection in HIV-positive patients
From: Low prevalence of H. pylori Infection in HIV-Positive Patients in the Northeast of Brazil
Variables | H. pylori+ N (%) | Total | p-value |
|---|---|---|---|
Gender | |||
Female | 17 (39.5) | 43 | 0.68 |
Male | 25 (35.7) | 70 | |
CD4 count | |||
≤200 | 17 (28.8) | 59 | 0.06 |
>200 | 25 (46.3) | 54 | |
Viral load | |||
<100.103 | 30 (42.8) | 71 | 0.11 |
≥100. 103 | 12 (27.9) | 42 | |
Antibiotics | |||
No | 23 (44.2) | 52 | 0.15 |
Yes | 19 (31.1) | 61 | |
Use of H2-blocker | |||
No | 31 (38.3) | 76 | 0.25 |
Yes | 11 (16.6) | 37 | |
Antifungic therapy | |||
No | 36 (40.5) | 87 | 0.09 |
Yes | 6 (29.7) | 26 | |
Antiretroviral therapy HAART | |||
No | 12 (38.3) | 42 | 0.15 |
Yes | 30 (16.6) | 71 |